Navigation Links
New research suggests standardized booster seat laws could save lives of children
Date:11/5/2012

Boston, Mass, Nov. 5, 2012 A new study by researchers in Boston Children's Hospital's Division of Emergency Medicine indicates that a nationwide standard on booster seat laws for children 4 feet 9 inches and shorter, or up to 8 years old, would save lives. The findings were published online Nov. 5, 2012, in the journal Pediatrics.

Boston Children's researchers reviewed data from Fatality Analytic Reporting System, analyzing child deaths in motor vehicle accidents, looking specifically at whether the crash and resulting deaths or injuries took place in a state with or without a booster seat law. If the state did have a booster law, the team noted its age and height requirements. The results varied from state to state, as many state's booster seat laws have different age and height requirements, but overall findings were clear: states with booster seat laws had significantly fewer instances of death or injury from motor vehicle accidents, especially among children in the 6- to 7-year age group. Key findings include:

  • Out of 9,848 cases reviewed over a 10-year period, states with booster seat laws for children 4 to 6 had a roughly 20 percent lower rate of death and incapacitating injuries from motor vehicle crashes than states without booster seat laws.
  • States with booster seat laws that extended to 6- and 7-year-olds had a 35 percent decreased rate of death or incapacitating injury.

The AAP recommends that children be placed in belt-positioning booster seats after they grow too large for a car seataround 4 years oldand until the child attains a height of about 4 feet 9 inches, usually around 8 to 12 years old. Without boosters, many children shorter than 4 feet 9 inches run the risk of having the seat belt rest on their throat and abdomen, instead of their chest and lap. In the event of a crash, belts in that position may cause serious, even fatal, injuries to the intestines and spine.

Despite the effectiveness of booster seats in preventing this type of injury among children, usage remains low. According to reports, booster seats are used by only about half of children 4 to 5 years old and 35 percent of those 6 to 7 years old.

"Based on our findings, booster seat use for children under the age of 8 or 4 feet 9 inches really should go beyond causal suggestion," says Rebekah Mannix, MD, MPH, of Boston Children's Division of Emergency Medicine, lead author on the paper. "It's clear that these laws save lives and we recommended all states adopt them."

"At the end of the day we all want children to be safe," adds Lois Lee, MD, MPH, co-author on the study. "Data show booster seat laws help protect children, and we hope it can convince lawmakers to adopt laws that require kids to be in the proper child passenger restraint (car seat and booster seat) until the recommended age and height."


'/>"/>

Contact: Meghan Weber
Meghan.Weber@childrens.harvard.edu
617-919-3110
Boston Children's Hospital
Source:Eurekalert

Related medicine news :

1. Medical care presents update on pharmaceutical health services research
2. Penn Medicines Daniel J. Rader, M.D., receives AHAs Clinical Research Prize
3. 23andMe demonstrates comprehensive research capabilities at annual meeting for ASHG
4. New research on employment-based insurance sheds light on health care reform
5. Forum to bring together leading-edge ophthalmic researchers and investors
6. Edith Sanford Breast Cancer Foundation and TSRI partner in genomic breast cancer research
7. George Mason University researchers target breast cancer in 3 trials
8. IU researchers report first effective treatment of tumors arising from common genetic disease NF1
9. OHSU researchers discover potential way to repair brain damage in multiple sclerosis
10. OU research team developing robotic devices to aid infants with cerebral palsy
11. Penn researchers find error reporting improves perceptions of safety and may reduce incidents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... Demand ... at the East-coast edition of MarTech: The Marketing Tech Conference October 2–4, at ... more than 40 speakers — representing such thought-leading companies as JP Morgan ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... service and innovation, the company recently unveiled a redesigned website. The new site ... the work of building owners, architects, contractors and other industry users that Garland ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... variety of settings, gather for the National Athletic Trainers’ Association Annual Clinical Symposium ... case studies presented. It is also when Athletic Trainers are acknowledged by their ...
(Date:9/20/2017)... ... September 20, 2017 , ... The Honey ... With Vaginas.” The goal is to ignite conversation via social media and word-of-mouth ... The brand has declared September “Humans with Vaginas” month, releasing a video celebrating ...
(Date:9/20/2017)... ... September 20, 2017 , ... The Centers for Medicare and ... that it will transition to using only Worksheet S-10 to distribute Disproportionate Share Hospital ... three live 60-minute complimentary webinars on October 17, 2017 at 2 P.M. ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 NeuroRx, a clinical ... Suicidal Ideation and Behavior (ASIB), has been granted Fast Track ... sequential therapy of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine ... a pivotal trial of this sequential therapy targeting patients who ... 1 ...
(Date:9/5/2017)... Pa. , Sept. 5, 2017  Xyntek Inc. has announced another milestone ... a new Midwest office to meet the growing demands of customer engagements regionally.  ... Xyntek's new Midwest office is located at 318 ... ... of customer engagements regionally. ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... company focused on the development of oral drug delivery ... meeting with the U.S. Food and Drug Administration (FDA) ... At the meeting, the ... submission of ORMD-0801, would be a Biologics License Application ...
Breaking Medicine Technology: